Exhibit 99.2

CONSENT TO BE NAMED

I hereby confirm my consent to be named as a director of Dermata Therapeutics, Inc. (the “Company”), in the Registration Statement on Form S-1 filed by the Company with the Securities and Exchange Commission, including any and all amendments and post-effective amendments thereto and any amendments filed under Rule 462(b) (collectively, the “Registration Statement”). This consent may be filed as an exhibit to the Registration Statement.

 

DATED: April 26, 2021		/s/ Andrew Sandler, M.D.
		Andrew Sandler, M.D.